Nextplat (NXPL) had the highest return in September 2019 by a US stock in the Nasdaq Composite (IXIC), returning 1,317.4%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Nextplat (NXPL) | September 2019 | 1,317.39% |
Lexicon Pharmaceuticals (LXRX) | September 2019 | 122.96% |
T2 Biosystms (TTOO) | September 2019 | 103.25% |
Interlink Electronics (LINK) | September 2019 | 100.01% |
111 (YI) | September 2019 | 95.58% |
Apptech (APCX) | September 2019 | 83.64% |
Ovid Therapeutics (OVID) | September 2019 | 83.05% |
TheRealReal (REAL) | September 2019 | 70.17% |
Avadel Pharmaceuticals (AVDL) | September 2019 | 66.4% |
Edesa Biotech (EDSA) | September 2019 | 60.98% |
Maiden (MHLD) | September 2019 | 59.07% |
Kazia Therapeutics Ltd ADR (KZIA) | September 2019 | 56.9% |
Metalpha Technology (MATH) | September 2019 | 56.57% |
Organogenesis (ORGO) | September 2019 | 56.43% |
VistaGen Therapeutics (VTGN) | September 2019 | 55.07% |
Bicycle Therapeutics (BCYC) | September 2019 | 52.48% |
Verrica Pharmaceuticals (VRCA) | September 2019 | 51.54% |
Eterna Therapeutics (ERNA) | September 2019 | 51.35% |
Gogo (GOGO) | September 2019 | 50.75% |
InnovAge (INNV) | September 2019 | 50% |
Capricor Therapeutics (CAPR) | September 2019 | 48% |
Lands’ End (LE) | September 2019 | 47.34% |
Scienture (SCNX) | September 2019 | 46.67% |
EchoStar (SATS) | September 2019 | 44.41% |
Mesoblast (MESO) | September 2019 | 42.89% |
